SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Microcap Kitchen Canadian Stocks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Acton who wrote (24511)5/30/2014 1:53:25 PM
From: Hodor  Read Replies (3) of 49402
 
I know TLT is a day traders wet dream. But for myself I am long on TLT. If they can do a successful launch of the TLC-2000 later this year with a new recurring revenue model, I see that side of the business alone worth $0.30 - $0.40. The cancer side is the shoot for stars with little risk in my eyes.

Remember they have identified 4 PDC's (if I remember correctly) that show great results with multiple cancers and certain bacterias. They are focusing on the one cancer at the moment that has the best chance to get Breakthrough status and get them to market next year.

On the negative side, they do have several million in the bank from capital raising last November, but I think they will need to raise more before the revenue on the TLC-2000 fully kicks in. However, after it does they shouldn't need to raise anymore after that.

Good luck to the day traders, there is money to be made. But hopefully more luck to the long term investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext